Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8243846 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 9 Pages |
Abstract
Conclusions: Genetic polymorphisms in XPF/ERCC1, XPG/ERCC5, and XPA may significantly influence response to radiotherapy; large studies are warranted to confirm their role in HNSCC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Joan M.D., Ph.D., Mariano M.D., Ph.D., Marta M.D., Ph.D., Sonia Ph.D., Rosa Ph.D., Alfons Ph.D., Palmira M.D., Ph.D., Francesc M.D., Ph.D., Angel M.D., Ph.D., Bernat Ph.D., Maribel M.D., Ph.D., Joan M.D., Ph.D., Xavier M.D., Ph.D.,